Details for New Drug Application (NDA): 018927
✉ Email this page to a colleague
The generic ingredient in TEGRETOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 018927
Tradename: | TEGRETOL |
Applicant: | Novartis |
Ingredient: | carbamazepine |
Patents: | 0 |
Suppliers and Packaging for NDA: 018927
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TEGRETOL | carbamazepine | SUSPENSION;ORAL | 018927 | NDA | Novartis Pharmaceuticals Corporation | 0078-0508 | 0078-0508-83 | 450 mL in 1 BOTTLE (0078-0508-83) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Dec 18, 1987 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 018927
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TEGRETOL | carbamazepine | SUSPENSION;ORAL | 018927-001 | Dec 18, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription